The tumor was analyzed by fluorescence in situ hybridization (FISH), and revealed the absence of DDIT3 alteration (Fig. 4) or MDM2 amplification, thus supporting the diagnosis of DFML and excluding a diagnosis of myxoid liposarcoma. The gene discussed is MDM2; the disease is neoplasm.